We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-1.23%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.32B
AUM Growth
-$43.4M
Cap. Flow
-$78.2M
Cap. Flow %
-5.91%
Top 10 Hldgs %
42.88%
Holding
161
New
23
Increased
29
Reduced
44
Closed
16

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$14.7M
2
GXO icon
GXO Logistics
GXO
+$12.6M
3
CCOI icon
Cogent Communications
CCOI
+$9.55M
4
HHH icon
Howard Hughes
HHH
+$8.22M
5
SOLV icon
Solventum
SOLV
+$7.59M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$22.6M
2
R icon
Ryder
R
+$11.5M
3
ERO icon
Ero Copper
ERO
+$8.91M
4
SN icon
SharkNinja
SN
+$8.8M
5
ENVA icon
Enova International
ENVA
+$8.8M

Sector Composition

Rank Sector Weight
1 Healthcare 21.21%
2 Consumer Discretionary 18.2%
3 Financials 6.25%
4 Materials 4.03%
5 Industrials 3.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOLV icon
51
Solventum
SOLV
$14.8B
$6.61M 0.5%
+125,000
New +$7.59M
SBLK icon
52
Star Bulk Carriers
SBLK
$3.21B
$5.73M 0.43%
235,000
+35,000
+18% +$870K
GOOG icon
53
PUT
Alphabet (Google) Class C
GOOG
$4.36T
$5.5M 0.42%
30,000
-40,000
-57% -$6.8M
SAGE
54
DELISTED
Sage Therapeutics
SAGE
$5.43M 0.41%
500,000
+300,000
+150% +$3.84M
GOSS icon
55
Gossamer Bio
GOSS
$82.9M
$5.18M 0.39%
5,750,000
+2,500,000
+77% +$1.87M
CRL icon
56
PUT
Charles River Laboratories
CRL
$11.2B
$5.16M 0.39%
+25,000
New +$5.66M
CCTS
57
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
$5.11M 0.39%
450,000
– –
BBIO icon
58
BridgeBio Pharma
BBIO
$15.7B
$5.07M 0.38%
200,000
+110,000
+122% +$3.01M
PCSC
59
DELISTED
Perceptive Capital Solutions
PCSC
$5.03M 0.38%
+500,000
New +$5.04M
AGRO icon
60
Adecoagro
AGRO
$1.44B
$4.87M 0.37%
+500,000
New +$5.18M
VIGL
61
DELISTED
Vigil Neuroscience
VIGL
$4.4M 0.33%
1,100,000
+105,100
+11% +$360K
ROIV icon
62
Roivant Sciences
ROIV
$24.5B
$4.33M 0.33%
410,000
+139,866
+52% +$1.53M
IVVD icon
63
Invivyd
IVVD
$158M
$3.99M 0.3%
3,625,000
+150,000
+4% +$331K
CZR icon
64
PUT
Caesars Entertainment
CZR
$6.06B
$3.97M 0.3%
+100,000
New +$3.76M
ZVRA icon
65
Zevra Therapeutics
ZVRA
$562M
$3.92M 0.3%
800,000
– –
GEHC icon
66
PUT
GE HealthCare
GEHC
$30.7B
$3.9M 0.29%
50,000
– –
IFRX icon
67
InflaRx
IFRX
$250M
$3.6M 0.27%
2,070,000
+1,200,000
+138% +$1.76M
AFMD
68
DELISTED
Affimed
AFMD
$3.54M 0.27%
650,000
-19,998
-3% -$112K
MRNA icon
69
Moderna
MRNA
$21.8B
$3.4M 0.26%
+28,629
New +$3.62M
IRS.WS
70
DELISTED
IRSA Inversiones y Representaciones S.A. Warrants
IRS.WS
$3.38M 0.26%
4,671,470
-1,012,282
-18% -$793K
MDGL icon
71
PUT
Madrigal Pharmaceuticals
MDGL
$10.8B
$3.22M 0.24%
11,500
-166,400
-94% -$39.6M
BTI icon
72
British American Tobacco
BTI
$131B
$3.09M 0.23%
+100,000
New +$3.04M
SLNO
73
DELISTED
Soleno Therapeutics
SLNO
$2.86M 0.22%
70,000
-8,000
-10% -$339K
AMLX icon
74
Amylyx Pharmaceuticals
AMLX
$2.26B
$2.85M 0.22%
+1,501,871
New +$2.91M
SMRT icon
75
SmartRent
SMRT
$195M
$2.65M 0.2%
1,107,569
+361,721
+48% +$887K
1 2
3
4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, 683 Capital Management held 161 positions worth $1.32B, down 3.2% from $1.37B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

683 Capital Management withdrew a net $78.2M in Q2 2024, closing 16 positions and reducing 44 holdings. Its most notable exit was Alphabet (Google) Class A, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, 683 Capital Management opened a new position in Philip Morris worth $15.2M.

  • 683 Capital Management's largest Q2 2024 buy was Philip Morris: 150,000 shares worth $15.2M.
  • 683 Capital Management added most to Cogent Communications in Q2 2024, an estimated $9.55M increase.
  • 683 Capital Management's biggest Q2 2024 reduction was Ryder, cutting an estimated $11.5M.
  • 683 Capital Management fully exited Alphabet (Google) Class A in Q2 2024, selling an estimated $22.6M.
  • 683 Capital Management's ten largest holdings make up 43% of its $1.32B portfolio in Q2 2024.
  • 683 Capital Management opened 23 new positions and closed 16 in Q2 2024.
  • 683 Capital Management's portfolio value fell 3.2% quarter-over-quarter to $1.32B.

Based on 683 Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.